Építés alatt – nem éles oldal
Belépés
Résztvevőt keresFázis nélkül

Natural History and Genotype-Phenotype Correlations in Mitochondrial Leukoencephalopathies

A legfontosabb adatok

Ki végzi
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Hol
Olaszország1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Toboroz
Résztvevők
100 fő, tervezett
Kezdés
2025. szept. 15.
Várható befejezés
2026. dec.
A vizsgálat típusa
Megfigyeléses
A regiszteradat frissítve
2026. október 9.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for people with a confirmed mitochondrial leukoencephalopathy, a genetic energy disorder that damages the brain's white matter. It studies existing medical records.

Nem
All sexes can join.
A betegség stádiuma
Diagnosis confirmed by an MRI pattern of white matter changes that fits leukoencephalopathy.
Biomarker vagy leletérték
A disease-causing gene change (pathogenic variant) in nuclear or mitochondrial genes.

A részvétel fő kizáró okai

  • Diagnosis not confirmed by MRI or by genetic testing.
  • Medical records missing key details on symptom start, disease course, brain scans or care.
  • Another genetic disorder that could also cause white matter damage or nerve symptoms.
  • No written informed consent from the patient, guardian or next of kin.

A regiszter feltételei, szó szerint

Mind a 7 feltétel megnézéseKevesebb

Ki vehet részt

  • Confirmed diagnosis of ML, confirmed by:; Neuroradiological evidence of a MRI pattern of white matter alterations compatible with leukoencephalopathy; Genetic evidence of pathogenic variants in nuclear or mitochondrial genes
  • Availability of clinical data, including medical records detailing symptom onset, disease progression, neuroimaging findings, and clinical management
  • Written informed consent obtained from the patient or their legal guardian (for minors or individuals with cognitive impairment). If the patient is deceased, consent for the use of medical records in this study will be obtained from the legally authorized representative or next of kin

Ki nem vehet részt

  • Concomitant diagnosis of another genetic disorder that may independently contribute to white matter abnormalities or neurological symptoms, confounding the assessment of ML progression and clinical outcomes
  • Insufficient clinical data, including cases where medical records lack essential information on symptom onset, disease progression, neuroimaging findings, or clinical management, preventing a meaningful contribution to the study's objectives
  • Unconfirmed diagnosis of mitochondrial leukoencephalopathy , including cases where:; MRI findings do not demonstrate a white matter alteration pattern compatible with leukoencephalopathy; There is neither genetic confirmation of a pathogenic variant in nuclear or mitochondrial genes
  • Unavailability of written informed consent

Ez a vizsgálat jelenleg itt érhető el: Olaszország.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

Mitochondrial disorders (MDs) are among the most common inherited metabolic diseases, caused by genetic defects in mitochondrial or nuclear DNA that impair cellular energy production. The central nervous system (CNS) is frequently affected, due to its high energy demands. Within the broad clinical spectrum of MDs, mitochondrial leukoencephalopathies (MLs) have emerged as a distinct subgroup characterized by CNS white matter involvement.

A teljes eredeti leírásKevesebb

MLs are clinically and genetically heterogeneous, with onset ranging from infancy to adulthood. Patients may experience episodes of neurological regression, often triggered by stressors such as febrile illnesses, alongside variable motor, cognitive, and occasionally extraneurological involvement. Neuroimaging typically reveals diffuse or focal white matter abnormalities, including cavitation and rarefaction, with additional involvement of deep gray matter structures. Certain ML subtypes exhibit characteristic MRI patterns that may aid in diagnosis.

Despite recent advancements in the genetic and neuroradiological characterization of MLs, significant knowledge gaps persist. Although the number of disease-causing genes has increased over the last decades, a comprehensive understanding of genotype-phenotype correlations is still lacking. Additionally, knowledge on the natural history of these disorders is limited. Existing data often focus on imaging findings with insufficient integration of clinical, biochemical, and molecular features, limiting the understanding of disease mechanisms, progression, and therapeutic responses.

In light of these gaps, this multicenter, observational, retrospective study aims to systematically collect and analyze clinical, biochemical, neuroradiological, and genetic data from individuals with MLs, assessed at international reference centers for MDs. The study seeks to better elucidate the phenotypic variability and genotype-phenotype correlations of MLs. This work is expected to enhance diagnostic accuracy, inform management strategies, support prognostic counseling, and ultimately contribute to the better overall management of affected individuals

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Natural History and Genotype-Phenotype Correlations in Mitochondrial Leukoencephalopathies: A Multicentric, International Observational Study
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 15.
A regiszteradat frissítve
2026. október 9.